Table 2.
Data set | Method | Pathogenic | Predicted SNVs |
---|---|---|---|
Lym168 | Fido-SNP | 119 (78.8%) | 168/168 (100.0%) |
SIFT | 70 (51.1%) | 137/168 (70.8%) | |
dog-omia | Fido-SNP | 64 (85.3%) | 75/75 (100.0%) |
SIFT | 43 (84.3%) | 51/75 (68.0%) |
Data set | Method | Pathogenic | Predicted SNVs |
---|---|---|---|
Lym168 | Fido-SNP | 119 (78.8%) | 168/168 (100.0%) |
SIFT | 70 (51.1%) | 137/168 (70.8%) | |
dog-omia | Fido-SNP | 64 (85.3%) | 75/75 (100.0%) |
SIFT | 43 (84.3%) | 51/75 (68.0%) |